0001209191-22-004092.txt : 20220120
0001209191-22-004092.hdr.sgml : 20220120
20220120171051
ACCESSION NUMBER: 0001209191-22-004092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220118
FILED AS OF DATE: 20220120
DATE AS OF CHANGE: 20220120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rutten Guillaume Marie Jean
CENTRAL INDEX KEY: 0001596796
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29472
FILM NUMBER: 22543101
MAIL ADDRESS:
STREET 1: 1900 S. PRICE ROAD
CITY: CHANDLER
STATE: AZ
ZIP: 85286
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMKOR TECHNOLOGY, INC.
CENTRAL INDEX KEY: 0001047127
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 231722724
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2045 EAST INNOVATION CIRCLE
CITY: TEMPE
STATE: AZ
ZIP: 85284
BUSINESS PHONE: 480-821-5000
MAIL ADDRESS:
STREET 1: 2045 EAST INNOVATION CIRCLE
CITY: TEMPE
STATE: AZ
ZIP: 85284
FORMER COMPANY:
FORMER CONFORMED NAME: AMKOR TECHNOLOGY INC
DATE OF NAME CHANGE: 19971001
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-18
0
0001047127
AMKOR TECHNOLOGY, INC.
AMKR
0001596796
Rutten Guillaume Marie Jean
2045 EAST INNOVATION CIRCLE
TEMPE
AZ
85284
1
1
0
0
President and CEO
Common Stock
2022-01-18
4
M
0
10000
14.17
A
330000
D
Common Stock
2022-01-18
4
S
0
25000
23.78
D
305000
D
Employee Stock Option (Right-to-Buy)
14.17
2022-01-18
4
M
0
10000
0.00
D
2020-10-30
2030-07-30
Common Stock
10000
232500
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.57 to $24.47.The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
This stock option (the "Option") to acquire 375,000 shares of the Issuer's common stock was granted on July 30, 2020 (the "Grant Date") and will vest in equal quarterly installments over three years, such that 100% of the Option will be vested on the third anniversary of the Grant Date.
Mark N. Rogers, Attorney-in-Fact for Guillaume Marie Jean Rutten
2022-01-20